Amazon.com Inc vs Cardinal Health Inc — how do they compare? Amazon.com Inc trades at $248.2 (market cap $2.64T), while Cardinal Health Inc trades at $234.7 (market cap $55.23B). The key difference: Amazon.com Inc is far larger — about 47.8× Cardinal Health Inc's market cap, and Cardinal Health Inc pays a 0.87% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| AMZN | CAH | |
|---|---|---|
Market Cap | $2.64T | $55.23B |
Volume | 3,931,282 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $274.95 | $239.71 |
52-Week Low | $198.79 | $146.04 |
Enterprise Value | $2.71T | $60.20B |
Dividend Yield | — | 0.87% |
Signals from Pluang's Aura AI — not financial advice
Amazon (AMZN) trades at $247.80, up 1.0% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growing to $716.92B in 2025 and net income reaching $77.67B. Recent Q1 2026 earnings beat expectations significantly at $2.78 EPS versus $1.63 expected. Technical indicators show the stock trading near resistance at $249 with RSI suggesting mild overbought conditions at 71.32.
Amazon presents a compelling investment case with strong analyst support (88.3% buy rating) and a $320.75 consensus price target representing 29% upside. However, risks include aggressive capital expenditures ($142.55B investing outflow in 2025) and intensifying competition in e-commerce and cloud services. The stock's premium valuation (P/E 29.35) requires continued execution on AI initiatives and AWS growth to justify current levels.
Cardinal Health (CAH) trades at $235.80, up 0.87% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 37.08% ROE and positive revenue growth trends from $222.58B in 2025 to projected $250.7B in 2026. Recent removal from Russell indices has not dampened analyst optimism, with 54.55% maintaining buy ratings and a $248 consensus price target representing 5% upside potential.
The outlook remains positive given CAH's defensive healthcare distribution business and specialty pharma expansion. Key risks include negative shareholder equity of -$3.21B and elevated debt levels with 16.09% debt-to-asset ratio. Earnings momentum from three consecutive quarterly beats supports the bullish case, though investors should monitor the upcoming Q2 2026 results against $2.41 EPS expectations.
Trailing returns across standard periods
Latest headlines on both assets
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →